Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nübling

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Vox Sanguinis|November 13, 2001
Human T-cell lymphocytotrophic virus prevalence in German blood donors and "at-risk" groupsM Nübling, C M Nübling, E Seifried, et al.
Lancet (London, England)|January 6, 1996
GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulinC M Nübling, J Lŏwer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 30, 2014
[Legal basis and practice of examination of critical in vitro diagnostic devices]C M Nübling, S Nick
Anaesthesia|August 10, 2013
Patient satisfaction with anaesthesia - Part 2: construction and quality assessment of questionnairesM Nübling, D Saal, T Heidegger
Anaesthesia|August 10, 2013
Patient satisfaction with anaesthesia - Part 1: satisfaction as part of outcome - and what satisfies patientsT Heidegger, D Saal, M Nübling
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2000
Validation of HCV-NAT assays and experience with NAT application for blood screening in GermanyC M Nübling, M Chudy, J Löwer
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 14, 2013
Heat-related mortality in Freiburg and Rostock in 2003 and 2005 - methodology and resultsM-I Bittner, M Nübling, U Stössel
Infection|May 23, 2002
Occupational risk for hepatitis A and hepatitis E among health care professionals?M Nübling, F Hofmann, F W Tiller
Lancet (London, England)|May 6, 1995
Hepatitis C transmission associated with intravenous immunoglobulinsC M Nübling, H Willkommen, J Löwer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Regulatory aspects of clinical trials with emphasis on biologicals]P Volkers, S Poley-Ochmann, M Nübling
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Vox Sanguinis|November 13, 2001
Human T-cell lymphocytotrophic virus prevalence in German blood donors and "at-risk" groupsM Nübling, C M Nübling, E Seifried, et al.
Lancet (London, England)|January 6, 1996
GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulinC M Nübling, J Lŏwer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 30, 2014
[Legal basis and practice of examination of critical in vitro diagnostic devices]C M Nübling, S Nick
Anaesthesia|August 10, 2013
Patient satisfaction with anaesthesia - Part 2: construction and quality assessment of questionnairesM Nübling, D Saal, T Heidegger
Anaesthesia|August 10, 2013
Patient satisfaction with anaesthesia - Part 1: satisfaction as part of outcome - and what satisfies patientsT Heidegger, D Saal, M Nübling
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2000
Validation of HCV-NAT assays and experience with NAT application for blood screening in GermanyC M Nübling, M Chudy, J Löwer
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 14, 2013
Heat-related mortality in Freiburg and Rostock in 2003 and 2005 - methodology and resultsM-I Bittner, M Nübling, U Stössel
Infection|May 23, 2002
Occupational risk for hepatitis A and hepatitis E among health care professionals?M Nübling, F Hofmann, F W Tiller
Lancet (London, England)|May 6, 1995
Hepatitis C transmission associated with intravenous immunoglobulinsC M Nübling, H Willkommen, J Löwer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Regulatory aspects of clinical trials with emphasis on biologicals]P Volkers, S Poley-Ochmann, M Nübling
Pageof 6